Forodesine (Fodosine)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 19:40, 12 November 2014 by Jwarner (talk | contribs) (Jwarner moved page Forodesine to Forodesine (Fodosine): Added brand name.)
Jump to navigation Jump to search

Mechanism of action

Purine nucleoside phosphorylase (PNP) inhibitor

Preliminary data

T-cell lymphoma

  1. Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. link to original article PubMed

Also known as

Immucillin H

Retrieved from "https://hemonc.org/w/index.php?title=Forodesine_(Fodosine)&oldid=5632"